These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 598562)

  • 1. The effect of somatostatin on platelets: in vivo and in vitro studies.
    Scheck R; Raptis S; Rasche H; Escobar-Jimenez F
    Diabete Metab; 1977 Dec; 3(4):219-22. PubMed ID: 598562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of somatostatin on coagulation and platelet function in man.
    Mielke CH; Gerich JE; Lorenzi M; Tsalikian E; Rodvien R; Forsham PH
    N Engl J Med; 1975 Sep; 293(10):480-3. PubMed ID: 1152862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of somatostatin on platelet aggregation and plasma factor VIII level in normal man.
    Bensoussan D; Levy-Toledano S; Passa P; Caen J; Canivet J
    Diabete Metab; 1977 Dec; 3(4):223-7. PubMed ID: 304425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating platelet aggregates induced by somatostatin in insulin-dependent diabetic subjects.
    Coppola L; Giugliano D; Tirelli A; Misso L; Sgambato S; D'Onofrio F
    Diabete Metab; 1980 Dec; 6(4):245-9. PubMed ID: 6110570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of aspirin induced changes in bleeding time, platelet aggregation, and Sonoclot coagulation analysis in humans.
    Samra SK; Harrison RL; Bee DE; Valero V
    Ann Clin Lab Sci; 1991; 21(5):315-27. PubMed ID: 1952780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelets release active matrix metalloproteinase-2 in vivo in humans at a site of vascular injury: lack of inhibition by aspirin.
    Falcinelli E; Giannini S; Boschetti E; Gresele P
    Br J Haematol; 2007 Jul; 138(2):221-30. PubMed ID: 17593030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibition of platelet aggregation under estrogen-treatment in patients with carcinoma of the prostate (author's transl)].
    Eisen M; Napp HE; Vock R
    Urologe A; 1975 May; 14(3):132-6. PubMed ID: 1154559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo effects of desmopressin on platelet function.
    Balduini CL; Noris P; Belletti S; Spedini P; Gamba G
    Haematologica; 1999 Oct; 84(10):891-6. PubMed ID: 10509036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of variable low doses of aspirin on platelet functions.
    Bose S; Roohi F; Shiralkar M
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):56-60. PubMed ID: 8132248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human-pharmacological investigations on the platelet adhesiveness- and aggregation-inhibiting effect of EMD 26 644, an oxazolyl-thio-propionic acid derivate.
    Jacobi E; Leopold G; Lissner R; Maisenbacher J
    Int J Clin Pharmacol Biopharm; 1978 Mar; 16(3):136-41. PubMed ID: 649232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bleeding disorders and acetylsalicylic acid ingestion. Clinical and biological repercussion in childhood].
    Blanco Quirós A; Valbuena C; Alvarez Guisasola FJ
    An Esp Pediatr; 1975; 8(1):48-57. PubMed ID: 1122082
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro and in vivo functions of thrombin-treated platelets.
    Reimers HJ; Kinlough-Rathbone RL; Cazenave JP; Senyi AF; Hirsh J; Packham MA; Mustard JF
    Thromb Haemost; 1976 Feb; 35(1):151-66. PubMed ID: 785686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impairment of platelet function by growth-hormone release-inhibiting hormone.
    Besser GM; Paxton AM; Johnson SA; Moody EJ; Mortimer CH
    Lancet; 1975 May; 1(7917):1166-8. PubMed ID: 48778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of desmopressin (DDAVP) on blood platelet parameters in vivo and in vitro].
    Kätzel R; Dietzel H; Selle B; Taube C
    Z Gesamte Inn Med; 1992 Jul; 47(7):303-7. PubMed ID: 1496839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Platelet function tests with clinical significance].
    Vicente García V
    Sangre (Barc); 1984; 29(4-C):783-97. PubMed ID: 6515513
    [No Abstract]   [Full Text] [Related]  

  • 17. The hemostatic mechanism after open-heart surgery. II. Frequency of abnormal platelet functions during and after extracorporeal circulation.
    McKenna R; Bachmann F; Whittaker B; Gilson JR; Weinberg M
    J Thorac Cardiovasc Surg; 1975 Aug; 70(2):298-308. PubMed ID: 1152513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies with the stabilized epoprostenol analogue taprostene. Effects on platelet functions and blood clotting.
    Michel G; Seipp U
    Arzneimittelforschung; 1990 Aug; 40(8):932-8. PubMed ID: 2242087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term, moderate dosage Vitamin E supplementation may have no effect on platelet aggregation, coagulation profile, and bleeding time in healthy individuals.
    Dereska NH; McLemore EC; Tessier DJ; Bash DS; Brophy CM
    J Surg Res; 2006 May; 132(1):121-9. PubMed ID: 16337968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.